Table 4.
Effect size and standardized response mean between baseline and 12 ± 3 days after DC
AF6 Items | All | Responders | Non-responders | |||
---|---|---|---|---|---|---|
ES | SRM | ES | SRM | ES | SRM | |
Breathing difficulties at rest | 0.01 | 0.00 | 0.11 | 0.10 | −0.13 | −0.13 |
Breathing difficulties upon exertion | 0.32 | 0.33 | 0.52 | 0.52 | 0.09 | 0.12 |
Limitations in day-to-day due to atrial fibrillation | 0.28 | 0.25 | 0.71 | 0.70 | −0.24 | −0.21 |
Feeling of discomfort due to atrial fibrillation | 0.29 | 0.28 | 0.59 | 0.64 | −0.13 | −0.10 |
Tiredness due to atrial fibrillation | 0.53 | 0.53 | 0.86 | 0.83 | 0.19 | 0.22 |
Worry/anxiety due to atrial fibrillation | 0.15 | 0.16 | 0.28 | 0.34 | −0.04 | 0.03 |
Effect sizes were characterized as small (>0.2 but <0.5), moderate (0.5-0.8) or large (>0.8)